JazzPharmaceuticals Innovation that performs
Home
About JazzPharmaceuticals
Our Products
News & Meetings
Partnering
Investors
Careers
Contact Us
Media Kit
  News
  Meetings
Media Kit
News & Meetings

08/07/2008 | Press Release
JAZZ PHARMACEUTICALS, INC. ANNOUNCES SECOND QUARTER 2008 FINANCIAL RESULTS - XYREM® SALES REACH RECORD $12.4 MILLION

07/24/2008 | Press Release
JAZZ PHARMACEUTICALS, INC. TO ANNOUNCE SECOND QUARTER RESULTS ON AUGUST 7, 2008

07/21/2008 | Press Release
JAZZ PHARMACEUTICALS ANNOUNCES CLOSING OF REGISTERED DIRECT OFFERING

07/16/2008 | Press Release
JAZZ PHARMACEUTICALS ANNOUNCES $26.0 MILLION REGISTERED DIRECT OFFERING

06/11/2008 | Press Release
JAZZ PHARMACEUTICALS FILES FORM S-3 REGISTRATION STATEMENTS



Join the Team

Take a look at the current career opportunities available at Jazz Pharmaceuticals and apply online.
Apply


Media Kit
View Printer Friendly Version of That Page
About Jazz Pharmaceuticals

Jazz Pharmaceuticals is focused on helping patients by meeting unmet medical needs in neurology and psychiatry with important and innovative therapeutic products. Jazz Pharmaceuticals is aggressively building its product portfolio through a combination of commercialization and development activities. Based in Palo Alto, California, the company is committed to working closely with patients, patient advocacy groups and healthcare professionals. Jazz Pharmaceuticals acquired Orphan Medical in 2005.


Corporate Information


Corporate Overview
 
Management Team
 
Partnering
 
Jazz Logo (EPS file)
 


© 2008 Jazz Pharmaceuticals, Inc. : Privacy Policy & Terms of Use
Home : About Us : Our Products : News & Meetings : Partnering : Investors : Careers : Contact Us : Site Map